Royalty Pharma RPRX Earnings Call Transcripts

NASDAQ RPRX
$65.26 +0.44 (+0.69%)
As of: Oct 29, 2026 · 2:30 PM EDT
10 earnings calls on file for Royalty Pharma, from Q4 2020 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Royalty Pharma Q2 2026 Earnings Call

Aug 5, 2026 7,571 words · 33 min read
  • Pablo LegorretaChief Executive Officer and Chairman of the Board
  • Marshall UristExecutive Vice President, Head of Research and Investments
  • Christopher HiteChairman, Partnering and Investments
  • Terrance CoyneExecutive Vice President, Chief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Royalty Pharma Earnings Call Transcripts

Calls10
LatestAug 5, 2026
SinceQ4 2020

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 10 Royalty Pharma transcripts Register to get access to Royalty Pharma’s earnings call transcripts.